Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Elizabeth McNally

Northwestern University at Chicago, Department: Internal Medicine/medicine

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Ikaika Therapeutics

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

Elizabeth McNally is the inventor on a patent related to using antibodies against LTBP4 as a therapeutic for muscular dystrophy. That patent has been assigned to a company that she is co-founder of, Ikaika Therapeutics, which is collaborating with another entity to develop anti-LTBP4 antibodies based on that intellectual property. This grant is looking to assess whether antibodies against LTBP4 have therapeutic potential. The grant will test similar technology to that being pursued by Ikaika Therapeutics and Ikaika Therapeutics could be perceived as benefitting from the work performed in this grant.

Listed Research Project
Regulating fibrosis and growth through latent TGFbeta binding proteins

PROJECT NARRATIVE Muscular dystrophy is a disease where muscle is lost and replaced by fibrosis. We identified the LTBP4 gene and showed that it improves muscular dystrophy in mice and humans with Duchenne Muscular Dystrophy. We will define the mechanism by which LTBP4 improves muscular dystrophy and test an approach to manipulate LTBP4 to treat muscular dystrophy.

Filed on May 14, 2018.

Tell us what you know about Elizabeth McNally's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page